Related Experiment Video

Updated: Mar 21, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

14.0K

Adjuvant Therapy of Uveal Melanoma: Current Status

Pierre L Triozzi1, Arun D Singh2

  • 1Comprehensive Cancer Center of Wake Forest University, Winston-Salem, N.C., Ohio, USA.

Ocular Oncology and Pathology
|May 14, 2016
PubMed

Insights

Uveal melanoma patients face poor survival due to metastasis. Current adjuvant therapies are ineffective, necessitating novel treatments targeting genetic risk factors and promoting cellular dormancy for improved outcomes.

Area of Science:

  • Ophthalmology
  • Oncology
  • Medical Research

Background:

  • Uveal melanoma survival is limited by metastatic disease.
  • Adjuvant therapies post-primary tumor treatment have failed to prevent metastasis.

Purpose of the Study:

  • To review current challenges and developing strategies for uveal melanoma treatment.
  • To highlight the need for novel adjuvant therapies and clinical trial participation.

Main Methods:

  • Review of existing literature on uveal melanoma treatment and metastasis.
  • Analysis of emerging therapeutic approaches including immunotherapy and targeted agents.
  • Discussion of challenges posed by the rarity and biology of uveal melanoma.

Main Results:

  • Current adjuvant therapies lack efficacy in preventing uveal melanoma metastasis.
  • New strategies involve genetic profiling for risk stratification.
  • Novel immunotherapeutic, targeted agents, and differentiation/dormancy approaches are under development.

Conclusions:

  • Adjuvant therapy for uveal melanoma requires innovative approaches.
  • Personalized medicine using genetic criteria is crucial for identifying at-risk patients.
  • Participation in clinical trials is essential for advancing uveal melanoma treatment.
Keywords:
Adjuvant therapyMelanomaMetastasis

More Related Videos

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography05:46

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

2.3K
Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models06:16

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models

Published on: March 16, 2022

3.8K

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K